M.D. Sass LLC’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $72.3M | Buy |
|
|||||
|
2024
Q3 | $63.3M | Buy |
|
|||||
|
2024
Q2 | $63.8M | Buy |
|
|||||
|
2024
Q1 | $40.5M | Sell |
|
|||||
|
2023
Q4 | $42.8M | Sell |
|
|||||
|
2023
Q3 | $36.1M | Buy |
|
|||||
|
2023
Q2 | $36.9M | Buy |
|
|||||
|
2023
Q1 | $30.3M | Buy |
|
|||||
|
2022
Q4 | $28.3M | Sell |
|
|||||
|
2022
Q3 | $27.2M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $9.96M | Sell |
|
|||||
|
2020
Q3 | $13M | Sell |
|
|||||
|
2020
Q2 | $12.5M | Sell |
|
|||||
|
2020
Q1 | $10.9M | Buy |
|
|||||
|
2019
Q4 | $11.7M | Sell |
|
|||||
|
2019
Q3 | $13.3M | Buy |
|
|||||
|
2019
Q2 | $6.58M | Buy |
|